AGER and atherosclerosis: The authors demonstrated that administration of the soluble form of RAGE (sRAGE) may act as a decoy receptor for AGEs, inhibiting the binding of AGEs to membrane-bound RAGE (mRAGE) and thereby preventing the development and progression of atherosclerosis.